Dennis Carney

Serial Minimal Residual Disease Evaluation in Patients with Chronic Lymphocytic Leukemia Under Long-Term Venetoclax Treatment

Thomas Lew, Mary Ann Anderson, Constantine S Tam, Sasanka Handunnetti, Dennis Carney, Max Wolf, Surender Juneja, David Alan Westerman, Andrew W Roberts, John F Seymour

Conference Proceedings  |  2018  |  Blood

Plasmablastic Richter transformation as a resistance mechanism for chronic lymphocytic leukaemia treated with BCR signalling inhibitors

Kah-Lok Chan, Piers Blombery, Kate Jones, Stephen Lade, Dennis Carney, Huy Tran, John F Seymour, Constantine S Tam

Journal article  |  2017  |  British Journal of Haematology

Practical recommendations for the choice of anticoagulants in the management of patients with atrial fibrillation on ibrutinib

Khai Li Chai, Gail Rowan, John F Seymour, Kate Burbury, Dennis Carney, Constantine S Tam

Journal article  |  2017  |  Leukemia & Lymphoma

Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy

Thomas E Lew, Chan Y Cheah, Dennis A Carney, H Miles Prince, Max Wolf, Ali Bazargan, E Henry Januszewicz, Robin Filshie, David Westerman, John F Seymour, Constantine S Tam

Journal article  |  2016  |  Leukemia & Lymphoma

Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20( ) lymphoid malignancies

Andrew W Roberts, Ranjana H Advani, Brad S Kahl, Daniel Persky, John W Sweetenham, Dennis A Carney, Jianning Yang, Todd B Busman, Sari H Enschede, Roderick A Humerickhouse, John F Seymour

Journal article  |  2015  |  British Journal of Haematology

The utility and limitations of F-18-fluorodeoxyglucose positron emission tomography with computed tomography in patients with primary mediastinal B-cell lymphoma: single institution experience and literature review

Chan Y Cheah, Michael S Hofman, John F Seymour, David S Ritchie, Michael Dickinson, Andrew Wirth, H Miles Prince, Max Wolf, Elchanan H Januszcewicz, Dennis A Carney, Kirsten E Herbert, Simon J Harrison, Kate L Burbury, Constantine S Tam

Journal article  |  2015  |  Leukemia & Lymphoma

Favorable Outcomes from Allogeneic and Autologous Stem Cell Transplantation for Patients with Transformed Nonfollicular Indolent Lymphoma

Diego Villa, Anupkumar George, John F Seymour, Cynthia L Toze, Michael Crump, Christina Lee, Rena Buckstein, Douglas A Stewart, David MacDonald, Ronan Foley, Anargyros Xenocostas, Mitchell Sabloff, Neil Chua, Felix Couture, Jean E Larouche, Sandra Cohen, Kerry J Savage, Joseph M Connors, Tony Panzarella, Dennis A Carney, et al.

Journal article  |  2014  |  Biology of Blood and Marrow Transplantation

A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma

CY Cheah, KE Herbert, K O'Rourke, GA Kennedy, A George, PL Fedele, M Gilbertson, SY Tan, DS Ritchie, SS Opat, HM Prince, M Dickinson, K Burbury, M Wolf, EH Januszewicz, CS Tam, DA Westerman, DA Carney, SJ Harrison, JF Seymour

Journal article  |  2014  |  British Journal of Cancer

Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy

Chan Y Cheah, Michael Dickinson, Michael S Hofman, Anupkumar George, David S Ritchie, H Miles Prince, David Westerman, Simon J Harrison, Kate Burbury, Max Wolf, Henry Januszewicz, Kirsten E Herbert, Dennis A Carney, Constantine Tam, John F Seymour

Journal article  |  2014  |  Annals of Hematology

All is not lost - the improving outcome of patients with chronic lymphocytic leukaemia failing frontline therapy with fludarabine, cyclophosphamide and rituximab

Chan Y Cheah, Thomas E Lew, Rebecca Lee, Constantine S Tam, John F Seymour, Dennis A Carney

Journal article  |  2013  |  European Journal of Haematology

Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy

CY Cheah, MS Hofman, M Dickinson, A Wirth, D Westerman, SJ Harrison, K Burbury, M Wolf, H Januszewicz, K Herbert, HM Prince, DA Carney, DS Ritchie, RJ Hicks, JF Seymour

Journal article  |  2013  |  British Journal of Cancer

New Strategies to Direct Therapeutic Targeting of PML to Treat Cancers.

Kamil Wolyniec, Dennis A Carney, Sue Haupt, Ygal Haupt

Journal article  |  2013  |  Frontiers in Oncology

The tumor suppressor function of the promyelocytic leukemia (PML) protein was first identified as a result of its dysregulation in..

Emergence of central nervous system myeloma in the era of novel agents

Shane A Gangatharan, Dennis A Carney, H Miles Prince, Max M Wolf, E Henry Januszewicz, David S Ritchie, Simon J Harrison

Journal article  |  2012  |  Hematological Oncology

No evidence for DNA methylation of the ATM promoter CpG island in chronic lymphocytic leukemia

Thomas Mikeska, Dennis A Carney, John F Seymour, Alexander Dobrovic

Journal article  |  2012  |  Leukemia and Lymphoma

Local experience with the novel human anti-CD20 antibody, ofatumumab, as salvage treatment for patients with heavily pretreated chronic lymphocytic leukaemia

CY Cheah, DA Carney, SM Lim, H Januszewicz, J Scarlett, JF Seymour

Journal article  |  2012  |  Internal Medicine Journal

Rapid detection of FLT3 exon 20 tyrosine kinase domain mutations in patients with acute myeloid leukemia by high-resolution melting analysis

Angela Y-C Tan, Stephen Q Wong, Charlotte Guldborg Nyvold, Dennis A Carney, Andrew Wei, John F Seymour, Peter Hokland, undefined Westerman, Alexander Dobrovic

Journal article  |  2012  |  Leukemia and Lymphoma

Histone deacetylase inhibitors are unable to synergize with ABT-737 in killing primary chronic lymphocytic leukaemia cells in vitro

R Ralli, KM Banks, AP Wiegmans, D Carney, JF Seymour, RW Johnstone, AE Alsop

Journal article  |  2012  |  Leukemia

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy

DA Carney, DA Westerman, CS Tam, A Milner, HM Prince, M Kenealy, M Wolf, EH Januszewicz, D Ritchie, N Came, JF Seymour

Journal article  |  2010  |  Leukemia

Therapy-related myelodysplasia and fludarabine combination therapy - do the benefits justify the risk?

Dennis A Carney, John F Seymour

Journal article  |  2010  |  Leukemia and Lymphoma

Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparator

KE Herbert, S Morgan, HM Prince, DA Westerman, MM Wolf, DA Carney, K Yuen, J di Iulio, JF Seymour

Journal article  |  2009  |  Leukemia

Detection of NPM1 exon 12 mutations and FLT3-internal tandem duplications by high resolution melting analysis in normal karyotype acute myeloid leukemia

Angela YC Tan, David A Westerman, Dennis A Carney, John F Seymour, Surender Juneja, Alexander Dobrovic

Journal article  |  2008  |  Journal of Hematology & Oncology

Negative selection of chronic lymphocytic leukaemia cells using a bifunctional rosette-based antibody cocktail

Salim Essakali, Dennis Carney, David Westerman, Peter Gambell, John F Seymour, Alexander Dobrovic

Journal article  |  2008  |  BMC Biotechnology